|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.30 USD | -5.07% |
|
-10.62% | +9.65% |
| Jul. 20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| Jul. 07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 57.94 | 57.94 | 56.71 |
| Spread/Res. | -16.64% | -16.64% | -14.83% |
| Spread/Supp. | +1.94% | +1.94% | +20.72% |
| Support | 47.38 | 47.38 | 40.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
